RecruitingNot ApplicableNCT06250582

Does Virtual Reality Improve Symptom Burden in Dialysis Patients?


Sponsor

David Blum

Enrollment

20 participants

Start Date

Dec 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to investigate the use of virtual reality therapy in dialysis patients. The main question it aims to answer is: Does virtual reality improve symptom burden in dialysis patients and improve their mental wellbeing? Over a period of one month, one virtual reality therapy session of 30 minutes will be performed during each regular hemodialysis session. Since we will conduct a monocentric, crossover randomized controlled trial, the participants act as their own control group.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Older than 18 years;
  • in treatment with thrice-weekly hemodialysis sessions;
  • regular hemodialysis duration of three to five hours
  • having no visual impairment
  • having no acoustic deficit
  • patient must be capable of speaking and understanding German or English
  • no signs of cognitive impairment
  • patient oriented in time and space
  • being able to give informed consent as documented by signature

Exclusion Criteria2

  • diagnosis of epilepsy
  • current pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERvirtual reality therapy

A virtual reality therapy will be applied for 30 minutes. Patients will be wearing the glasses while lying in bed/chair during their regular dialysis session. Vital signs will be monitored repeatedly. At defined times, patients are asked to answer various questionnaires about their physical and mental health.


Locations(1)

University Hospital Zurich

Zurich, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06250582


Related Trials